Oragenics Inc. Files 8-K Report
Ticker: OGEN · Form: 8-K · Filed: May 17, 2024 · CIK: 1174940
Sentiment: neutral
Topics: sec-filing, 8-k, regulatory
Related Tickers: ORGN
TL;DR
ORGN filed an 8-K, standard SEC update, check for details.
AI Summary
On May 17, 2024, Oragenics, Inc. filed an 8-K report. The filing primarily serves as a notification of other events and includes financial statements and exhibits. No specific material events or financial figures were detailed in the provided excerpt.
Why It Matters
This filing indicates Oragenics, Inc. is providing updates and necessary documentation to the SEC, which is standard for public companies but may contain details relevant to investors.
Risk Assessment
Risk Level: low — The filing is a routine 8-K report without immediate disclosure of significant negative events.
Key Players & Entities
- Oragenics, Inc. (company) — Registrant
- May 17, 2024 (date) — Date of earliest event reported
- 1990 Main Street Suite 750 Sarasota, FL 34236 (address) — Principal executive offices
- 813 - 286-7900 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing for Oragenics, Inc.?
The filing is primarily to report 'Other Events' and to include 'Financial Statements and Exhibits' as of May 17, 2024.
What is Oragenics, Inc.'s state of incorporation and fiscal year end?
Oragenics, Inc. is incorporated in Florida (FL) and its fiscal year ends on December 31.
What is the business address and phone number for Oragenics, Inc.?
The business address is 1990 Main Street Suite 750, Sarasota, FL 34236, and the phone number is 813-286-7900.
What is the SEC file number for Oragenics, Inc.?
The SEC file number for Oragenics, Inc. is 001-32188.
What SIC code is associated with Oragenics, Inc.?
The Standard Industrial Classification (SIC) code for Oragenics, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 412 words · 2 min read · ~1 pages · Grade level 10.9 · Accepted 2024-05-17 08:00:41
Filing Documents
- form8-k.htm (8-K) — 38KB
- ex99-2.htm (EX-99.2) — 10KB
- 0001493152-24-020362.txt ( ) — 220KB
- ogen-20240517.xsd (EX-101.SCH) — 3KB
- ogen-20240517_lab.xml (EX-101.LAB) — 33KB
- ogen-20240517_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on this May 17, 2024. ORAGENICS, INC. (Registrant) BY: /s/ Janet Huffman Janet Huffman Chief Financial Officer